RISK/BENEFIT RATIO IN A REAL BRAIN (WHOLE-BRAIN) DISEASE (MEDICAL HEALTH VS. MENTAL HEALTH) > > The Kahn Gauthier Law Group is investigating possible legal actions against > Amarin Pharmaceuticals, Inc., the manufacturer of the prescription drug > Permax (pergolide mesylate), to recover for heart damage suffered by some > patients taking the drug. Permax is prescribed for patients suffering from > Parkinson's disease, a neurological disorder that causes shaking, freezing, > and other movement disorders. Concern over Permax has risen since the > publication of an article in the December, 2002, issue of the medical > journal Mayo Clinic Proceedings that revealed three cases of heart valve > disease in patients taking Permax.
[Fred A. Baughman Jr., MD:
Leave a Reply